enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. How To Be Active in Your Treatment Journey With COPD - AOL

   www.aol.com/active-treatment-journey-copd...

   Gordon didn’t know at the time that this episode was caused by COPD, a progressive disease that damages lungs and makes it hard to breathe. 1 Looking back, he recognizes there were many missed ...

3. A Guide for Living With COPD - AOL

   www.aol.com/guide-living-copd-210000074.html

   COPD is a risk factor for ... can continue to damage your lungs and increase your risk of exacerbations, ... above issues can minimize the symptoms and prevent complications from occurring. ...

4. Chronic obstructive pulmonary disease - Wikipedia

   en.wikipedia.org/wiki/Chronic_obstructive...

   Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by chronic respiratory symptoms and airflow limitation. [8] GOLD 2024 defined COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea or shortness of breath, cough, sputum production or exacerbations) due to abnormalities of the airways (bronchitis ...

5. Guard Against COPD at Every Stage of Life - AOL

   www.aol.com/news/guard-against-copd-every-stage...

   For people with chronic obstructive pulmonary disease (COPD), breathing is often front of mind because it can be difficult, and it gets worse over time. There is no cure yet for COPD, but experts ...

6. Acute exacerbation of chronic obstructive pulmonary disease

   en.wikipedia.org/wiki/Acute_exacerbation_of...

   E-nose showed the ability to smell the cause of the exacerbation. [8] The definition of a COPD exacerbation is commonly described as "lost in translation", [9] meaning that there is no universally accepted standard with regard to defining an acute exacerbation of COPD. Many organizations consider it a priority to create such a standard, as it ...

7. Erdosteine - Wikipedia

   en.wikipedia.org/wiki/Erdosteine

   The RESTORE study (Reducing Exacerbations and Symptoms by Treatment with ORal Erdosteine in COPD) was a multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of erdosteine 300 mg/bid added to usual maintenance therapy vs. placebo over 12-months, a period long enough to avoid bias due to seasonal ...